Heartflow (HTFL) Revenue & Revenue Breakdown
Heartflow Revenue Highlights
Latest Revenue (Y)
$176.03M
Latest Revenue (Q)
$64.08M
Main Geography (Y)
Non Us
Heartflow Revenue by Period
Heartflow Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $176.03M | 39.92% |
| 2024-12-31 | $125.81M | 44.32% |
| 2023-12-31 | $87.17M | - |
Heartflow generated $176.03M in revenue during NA 2025, up 39.92% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Heartflow Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $64.08M | 21.86% |
| 2026-03-31 | $52.59M | 7.04% |
| 2025-12-31 | $49.13M | 6.17% |
| 2025-09-30 | $46.28M | 6.57% |
| 2025-06-30 | $43.42M | 16.72% |
| 2025-03-31 | $37.20M | 6.37% |
| 2024-12-31 | $34.98M | 6.20% |
| 2024-09-30 | $32.93M | 6.05% |
| 2024-06-30 | $31.05M | 15.69% |
| 2024-03-31 | $26.84M | - |
Heartflow generated $64.08M in revenue during Q2 2026, up 21.86% compared to the previous quarter, and up 172.24% compared to the same period a year ago.
Heartflow Revenue Breakdown
Heartflow Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 25 |
|---|---|
| Non Us | $13.30M |
Latest
Heartflow's latest annual revenue breakdown by geography, as of Dec 25: Non Us (100.00%).
Quarterly Revenue by Country
| Country | Jun 26 | Mar 26 | Sep 25 | Jun 25 |
|---|---|---|---|---|
| Non Us | $3.77M | $3.60M | - | - |
| UNITED STATES | - | - | $42.95M | $39.99M |
| JAPAN | - | - | $1.46M | $1.53M |
| Rest Of Europe | - | - | $349.00K | $348.00K |
Latest
Heartflow's latest quarterly revenue breakdown by geography, as of Jun 26: Non Us (100.00%).
Heartflow Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PRGO | Perrigo | $4.25B | $1.02B |
| SGRY | Surgery Partners | $3.31B | $848.90M |
| PRVA | Privia Health Group | $2.12B | $632.63M |
| LIVN | LivaNova | $1.39B | $390.60M |
| TVTX | Travere Therapeutics | $490.73M | $169.58M |
| ZLAB | Zai Lab | $460.16M | $106.31M |
| TARS | Tarsus Pharmaceuticals | $451.36M | $173.91M |
| LEGN | Legend Biotech | $285.14M | $93.99M |
| HTFL | Heartflow | $176.03M | $64.08M |
| ATEC | Alphatec | - | $-192.11M |
| IRON | Disc Medicine | - | - |